Pioneering commercial CAR T cell therapy clinical development in India and South Asia

Published: 22 October 2021
Anil Kamat

Anil Kamat is a recognized clinical leader in hematology, with extensive experience in both clinical and manufacturing contexts. He is head of clinical development at Immuneel Therapeutics, based in Bengaluru, India, and serves as a consultant hematologist for the UK National Health Service. Dr Kamat is a member and contributor to several societies, including the International Society for Cell and Gene Therapy, the American Society of Hematology, and the European Group for Blood and Marrow Transplantation.

Read now